(Reuters) – Eli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger study later this year.
HEALTH NEWS
....the good, bad, sometimes ugly.
(Reuters) – Eli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger study later this year.
Comments are closed, but trackbacks and pingbacks are open.